Vulnerability · Published Jun 2, 2026 · Assigned by Roche
CVE-2026-9844Vulnerability in navify® Digital Pathology
High 8.8
In plain English
A high-severity security flaw in navify Digital Pathology from Roche Diagnostics. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 0.2% (higher than 15% of all known vulnerabilities).
Severity (CVSS 4.0)8.8High
Exploit odds (30 days)0.2%top 84.9% of all CVEs
Exploited in the wildNo reportsCISA SSVC: none
Attack toolingNoneno public tooling known
Official description
Use of default credentials vulnerability in Roche Diagnostics navify Digital Pathology (RabbitMQ Management interface modules) allows Default Usernames and Passwords. This issue affects navify Digital Pathology: from 2.0.0 before 2.4.1.
Affected products (as reported)
| Vendor | Product | Versions |
|---|---|---|
| Roche Diagnostics | navify Digital Pathology | 2.0.0 – through 2.4.1 |
Weakness: CWE-1392 · Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:H/VA:H/SC:L/SI:L/SA:L/S:N/AU:Y/R:U/V:D/RE:M/U:Green